Jove
Visualize
お問い合わせ
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 予測・予測マーカー
  6. 上部泌尿器官がんの診断が,人口ベースの対照群と比較して寿命に与える影響: 後回り分析
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 腫瘍学とがん発生
  5. 予測・予測マーカー
  6. 上部泌尿器官がんの診断が,人口ベースの対照群と比較して寿命に与える影響: 後回り分析

関連する実験動画

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

7.8K

上部泌尿器官がんの診断が,人口ベースの対照群と比較して寿命に与える影響: 後回り分析

Carolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello

    Urologia internationalis
    |September 2, 2025

    PubMed で要約を見る

    まとめ
    この要約は機械生成です。

    尿路上部泌尿器がん (UTUC) は,一般患者と比較して5年生存率を大幅に低下させる. 生存の格差は,転移性および局所的に進行したUTUCの段階で最も深刻です.

    科学分野:

    • 腫瘍学
    • 泌尿器科
    • 流行病学

    背景:

    • 尿路上部泌尿器がん (UTUC) は珍しい悪性腫瘍である.
    • 長期的な生存結果を理解することは 患者の管理に不可欠です

    研究 の 目的:

    • UTUC患者の5年間の全生存期 (OS) を,年齢と性別を合わせた対照群と比較する.
    • 病気の段階に基づく生存率の違いを分析する.

    主な方法:

    • 監視,疫学,最終結果 (SEER) データベース (2004-2020) を利用した.
    • 2004年から2015年の間に診断されたUTUC患者
    • 社会保障局のライフテーブルを用いたモンテカルロシミュレーションを用いた人口ベースのシミュレーションです.

    主要な成果:

    • 10,140人のUTUC患者は分析された: 39%は局所的,49%は局所的に進行し,12%は転移した.
    • 5年間の生存率はUTUC患者では41%で,対照群では78%でした (Δ 37%).
    • OSの違いは,転移 (4% 対 75%) と局所的に進行した (36% 対 78%) 段階で最も顕著でした.

    結論:

    さらに関連する動画

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
    09:28

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

    Published on: May 12, 2019

    10.3K
    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.1K

    関連する実験動画

    Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma
    06:39

    Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

    Published on: November 22, 2019

    7.8K
    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
    09:28

    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

    Published on: May 12, 2019

    10.3K
    Real-Time Void Spot Assay
    06:39

    Real-Time Void Spot Assay

    Published on: February 10, 2023

    2.1K

    関連する概念動画

    Urinary Tract Infection I: Introduction01:26

    Urinary Tract Infection I: Introduction

    47
    Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
    47
    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

    Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

    35
    A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
    35
    Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

    Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

    39
    Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
    39
    Nursing Assessment of the Genitourinary System I: Health History01:21

    Nursing Assessment of the Genitourinary System I: Health History

    75
    The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
    75
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    448
    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    448
    Urinary Tract Calculi V: Nursing Management01:28

    Urinary Tract Calculi V: Nursing Management

    27
    AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
    27
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    • UTUC患者の5年間の生存率は,対照群より著しく低い.
    • 転移性および局所的に進行したUTUCは生存の赤字が最も大きい.
    • UTUCは患者の平均寿命に大きく影響します 特に進行した段階でです